PVLA
#1973
Palvella Therapeutics, Inc. - Common Stock
146.8 2 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.10%
Variación mensual
+6.35%
Variación en los últimos 6 meses
+3.69%
Cambio anual
+98.81%
Cierres anteriores
149.9 7
Open
145.8 6
Mínimo
145.3 2
Máximo
146.8 2
Volumen
40
Financials
- Market Capitalization 2.12 B
- Employee 29
- Founded N/A
- CEO N/A
- Website www.palvellatx.com
- Headquarter Nevada, United States
- FIGI BBG0055C3N57
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-31.64
Relación precio/flujo de caja
474.82
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1712 |  MBX MBX Biosciences, Inc. - Common Stock | 60.32 USD | -4.25% | -9.09% | -8.59% | +303.75% | 2.91 B USD | ||
| 1914 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 47.73 USD | -2.13% | -3.01% | +16.90% | +82.25% | 2.29 B USD | ||
| 2017 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.92 USD | -2.67% | -13.21% | +5.67% | -0.53% | 1.92 B USD | ||
| 2176 |  MAZE Maze Therapeutics, Inc. - Common Stock | 25.99 USD | -5.28% | -11.54% | -2.80% | -42.28% | 1.44 B USD |